19 research outputs found
Number and percentage of distant metastases per molecular subtypes.
<p>Number and percentage of distant metastases per molecular subtypes.</p
Binomial distribution of molecular subtypes into luminal/non-luminal and HER2-positive/HER2-negative profiles in the case group compared to controls.
<p>Binomial distribution of molecular subtypes into luminal/non-luminal and HER2-positive/HER2-negative profiles in the case group compared to controls.</p
Distribution of ALN involvement according to luminal or non-luminal profiles.
<p>Distribution of ALN involvement according to luminal or non-luminal profiles.</p
Distribution of ALN involvement in case and control groups.
<p>Distribution of ALN involvement in case and control groups.</p
Proportion of tumor size categories in case and control groups.
<p>Proportion of tumor size categories in case and control groups.</p
Organ-specific metastatic risk according to binomial distribution of molecular subtypes into luminal/non-luminal profiles.
<p>Organ-specific metastatic risk according to binomial distribution of molecular subtypes into luminal/non-luminal profiles.</p
Proportion of grading features in case and control groups.
<p>Proportion of grading features in case and control groups.</p
Frequency of distant organ involvement by each breast cancer subtype.
<p>Frequency of distant organ involvement by each breast cancer subtype.</p
Organ-specific metastatic risk according to binomial distribution of molecular subtypes into HER2-positive/HER2-negative profiles.
<p>Organ-specific metastatic risk according to binomial distribution of molecular subtypes into HER2-positive/HER2-negative profiles.</p
Frequency of metastases associated with sites of breast cancer relapse.
<p>Frequency of metastases associated with sites of breast cancer relapse.</p